Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Low-Risk Medical Device Makers Get Clarity: CDSCO Publishes Class A Risk Classification List under MDR 2017

Omron to invest about USD 15.7 million to set up medical devices plant in Tamil Nadu

Ruchika Sharma31 May 2023 1:30 PM IST

Tamil Nadu state government said six other Japanese manufacturers had signed agreements to invest 8.19 billion rupees during a visit by state...

Apollo Hospitals Enterprise posts 7.6 per cent rise in Q4 profit

Ruchika Sharma31 May 2023 12:30 PM IST

Bengaluru: Indian healthcare services provider Apollo Hospitals Enterprise Ltd reported a 7.6 per cent rise in its fourth-quarter profit on Tuesday,...

Sun Pharma gets Chinese nod for plaque psoriasis injection Tildrakizumab

Ruchika Sharma31 May 2023 11:29 AM IST

ILUMETRI is a humanized, anti-IL-23p19 monoclonal antibody designed to selectively block the cytokine IL-23.

Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE Mark

Roche Canada, pan-Canadian Pharmaceutical Alliance complete negotiations for VABYSMO to treat Neovascular neovascular AMD, DME

Ruchika Sharma30 May 2023 5:46 PM IST

VABYSMO is a humanized bispecific immunoglobulin G1(IgG1) antibody that acts through inhibition of both Ang-2 and vascular endothelial growth factor A...

Novavax Nuvaxovid gets positive CHMP opinion for full marketing authorization for COVID prevention in EU

Ruchika Sharma30 May 2023 2:30 PM IST

Gaithersburg: Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M adjuvant, has announced that Nuvaxovid...

Natco Pharma net profit down 23.44 percent at Rs 517.9 crore in Q2

Natco Pharma posts Rs 715.3 crore of Profit after tax for year ended March 31st, 2023

Ruchika Sharma30 May 2023 1:30 PM IST

The profit for the fourth quarter, on a consolidated basis was INR 275.8 Crore, as against a loss of INR 50.5 Crore last year fourth quarter.

Sun Pharma Told to Revise Delafloxacin Phase III Trial Protocol

Sun Pharma, Philogen collaborate to commercialise anti-cancer biopharmaceutical Nidlegy in Europe, Australia and New Zealand

Ruchika Sharma30 May 2023 12:34 PM IST

The two partner companies will share post-commercialization economics in about 50:50 ratio.

Solara Active Pharma Sciences Mangalore facility successfully completes USFDA inspection

Jubilant Pharmova arm gets OAI status from USFDA for Montreal facility

Ruchika Sharma30 May 2023 11:48 AM IST

The US FDA in its communication mentioned it may withhold approval of any pending applications or supplements in which this facility is listed.

Sun Pharma appoints new Whole-time Director, Independent Director

Ruchika Sharma29 May 2023 3:33 PM IST

Mumbai: Sun Pharma has recently announced that the Company's Board has approved the appointment of Aalok Shanghvi as a Whole-time Director and...

Aurobindo Pharma arm Eugia Pharma B.V incorporates new wholly owned subsidiary in Chile

Aurobindo Pharma to sell shares in Auro Vaccines to Curateq Biologics

Ruchika Sharma29 May 2023 2:48 PM IST

Hyderabad: The Board of Directors of Aurobindo Pharma Limited has approved the sale and transfer of all equity shares held by the Company in...

Novo Nordisk gets EMA panel recommendation for once weekly Sogroya for expanded use in children, adolescents with growth hormone deficiency

Ruchika Sharma29 May 2023 1:30 PM IST

Sogroya is a prescription human growth hormone analogue, similar to current daily growth hormone and can be used to treat adults who do not produce...

Sun Pharma Sees LIC Cross 5% Holding Threshold

Sun Pharma proposes to fully acquire Taro Pharmaceutical Industries

Ruchika Sharma29 May 2023 12:30 PM IST

Under the indicative proposal, post the acquisition, Taro will become a wholly-owned subsidiary of Sun Pharma and will be delisted from NYSE.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok